Published in
Elsevier, Journal of Autoimmunity, (124), p. 102729, 2021
DOI: 10.1016/j.jaut.2021.102729
Links
Tools
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
Journal article published in 2021 by
Mariele Gatto 
,
Francesca Saccon,
Laura Andreoli ,
Elena Bartoloni ,
Francesco Benvenuti,
Alessandra Bortoluzzi,
Enrica Bozzolo,
Enrico Brunetta ,
Valentina Canti,
Paolo Cardinaletti,
Fulvia Ceccarelli,
Francesco Ciccia,
Fabrizio Conti,
Ginevra De Marchi,
Amato de Paulis
and other authors.
,
Francesca Saccon,
Laura Andreoli ,
Elena Bartoloni ,
Francesco Benvenuti,
Alessandra Bortoluzzi,
Enrica Bozzolo,
Enrico Brunetta ,
Valentina Canti,
Paolo Cardinaletti,
Fulvia Ceccarelli,
Francesco Ciccia,
Fabrizio Conti,
Ginevra De Marchi,
Amato de Paulis
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 